PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
about
The inhibitory effects of nicotine on physiological sexual arousal in nonsmoking women: results from a randomized, double-blind, placebo-controlled, cross-over trial.Vascular alterations and sexual function in systemic sclerosis.Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts.Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice.Zaprinast, a phosphodiesterase type-5 inhibitor, alters paced mating behavior in female rats.Effect of sildenafil on the activity of some antidepressant drugs and electroconvulsive shock treatment in the forced swim test in miceAntidepressant-like activity of sildenafil following acute and subchronic treatment in the forced swim test in mice: effects of restraint stress and monoamine depletion.Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice.Women's Sexual Health and Reproductive Function After SCI.
P2860
Q33808689-2B1644A5-2E39-4B8D-905A-E19451264D6EQ34218886-D5E1E354-D34C-4572-B2F3-2A7E2167C716Q34383988-1DC66D28-6688-4CA3-807D-E1AEA3520AB0Q36082944-38ABF8DF-4BA8-4394-980F-5038FEED697FQ37398011-B3F2262C-509B-4E21-B3F8-8B26F58DA5C1Q37693900-DE4E9ADA-6AB4-4290-9427-0E214F22CFE3Q40709156-BE12EC05-C441-454B-89E9-469FF8746EDDQ42177042-A5C93937-A5CF-457F-8366-8FE77BFFB87BQ47654017-945B3B99-8E4A-4FD4-B791-EB65C36A16E3
P2860
PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
@ast
PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
@en
type
label
PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
@ast
PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
@en
prefLabel
PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
@ast
PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
@en
P1476
PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
@en
P2093
Kevin E McKenna
Raymond C Rosen
P577
2002-01-01T00:00:00Z